TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34849019

Group type: EXPERIMENTAL
Intervention: 40mg chloroprocaine with 5 mcg spinal dexmedetomidine (Spinal Dexgroup)
Number of subjects: 135

Group type: COMPARATOR
Intervention: 40mg chloroprocaine (Chloro-group)
Number of subjects: 135

Group type: COMPARATOR
Intervention: 40mg chloroprocaine with 0.5 mcg/kg IV dexmedetomidine (IV DEXgroup)
Number of subjects: 135
Study: 35184665

Group type: EXPERIMENTAL
Intervention: Alzheimer's Cafè (AC) cognitive-behavior training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional cognitive training
Number of subjects: 20
Study: 33712844

Group type: EXPERIMENTAL
Intervention: SMARThealth intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 35282049

Group type: EXPERIMENTAL
Intervention: Loose combined cutting seton (LCCS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Incision and drainage
Number of subjects: 0
Study: 33351652

Group type: COMPARATOR
Intervention: Lethal means counseling
Number of subjects: 232

Group type: COMPARATOR
Intervention: Provision of cable locks
Number of subjects: 232
Study: 34570053

Group type: EXPERIMENTAL
Intervention: Nurse-led web-based health management program for 6 months
Number of subjects: 112
Study: 34564744

Group type: EXPERIMENTAL
Intervention: Radiomics signature based on pre-treatment CT scans
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Refined radiomics signature after identifying six independent predictive features
Number of subjects: 322
Study: 36494261

Group type: EXPERIMENTAL
Intervention: Full-dose S1
Number of subjects: 160

Group type: COMPARATOR
Intervention: Reduced-dose S1 + oxaliplatin
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: ECOG PS
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: G8
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: VES-13
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Frailty phenotype
Number of subjects: 160
Study: 33593336

Group type: EXPERIMENTAL
Intervention: Pharmacist-conducted education and follow-up
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard nursing counseling
Number of subjects: 200
Study: 33127634

Group type: EXPERIMENTAL
Intervention: Study definition of hyperkalaemia (serum potassium >5.5 mEq/L)
Number of subjects: 1266

Group type: EXPERIMENTAL
Intervention: Study definition of hypokalaemia (serum potassium <3.5 mEq/L)
Number of subjects: 1266

Group type: EXPERIMENTAL
Intervention: Risk of hyperkalaemia associated with unhealthy conditions
Number of subjects: 1266

Group type: EXPERIMENTAL
Intervention: Risk of hypokalaemia associated with unhealthy conditions
Number of subjects: 1266

Group type: EXPERIMENTAL
Intervention: Risk of hypokalaemia associated with older age
Number of subjects: 1266

Group type: EXPERIMENTAL
Intervention: Risk of hypokalaemia associated with region
Number of subjects: 1266

Group type: EXPERIMENTAL
Intervention: Higher serum potassium associated with male gender
Number of subjects: 1266

Group type: EXPERIMENTAL
Intervention: Higher serum potassium associated with estimated glomerular filtration rate <60 mL/min/1.73 m2
Number of subjects: 1266

Group type: EXPERIMENTAL
Intervention: Guidelines definition of hyperkalaemia
Number of subjects: 1266

Group type: EXPERIMENTAL
Intervention: Guidelines definition of hypokalaemia
Number of subjects: 1266
Study: 35378105

Group type: EXPERIMENTAL
Intervention: Functional training (24 one-hour sessions, three times a week, moderate intensity equivalent to 6-7 on the Borg scale)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Functional training
Number of subjects: 25
Study: 32481241

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) applied paraspinal alongside a physical exercise program (3 times/week for 3 months)
Number of subjects: 45
Study: 34115318

Group type: EXPERIMENTAL
Intervention: Lact. reuteri LR-99 probiotic (6 × 10^10 colony forming units)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Lact. reuteri LR-99 probiotic
Number of subjects: 71
Study: 32347692

Group type: EXPERIMENTAL
Intervention: FineVision toric PODFT (PhysIOL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Acrysof IQ PanOptix toric (Alcon)
Number of subjects: 60
Study: 35426564

Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 11
Study: 33785233

Group type: EXPERIMENTAL
Intervention: Intermittent traction with vibration (ITV)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Intermittent traction only (ITO)
Number of subjects: 95
Study: 36101719

Group type: EXPERIMENTAL
Intervention: Smartphone-based delivery (SPBD) of written educational materials
Number of subjects: 104

Group type: COMPARATOR
Intervention: Routine print delivery (PD) of educational materials
Number of subjects: 104
Study: 33103819

Group type: EXPERIMENTAL
Intervention: Ketogenic medium chain triglyceride (kMCT) drink; 15 g twice/day
Number of subjects: 83
Study: 35126621

Group type: EXPERIMENTAL
Intervention: High-flow oxygen therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Traditional oxygen therapy
Number of subjects: 120
Study: 34034362

Group type: EXPERIMENTAL
Intervention: Non-married participants
Number of subjects: 1171

Group type: COMPARATOR
Intervention: Married participants
Number of subjects: 1171
Study: 32370906

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 33217236

Group type: EXPERIMENTAL
Intervention: PIT + PT
Number of subjects: 50

Group type: COMPARATOR
Intervention: PT
Number of subjects: 50
Study: 32065827

Group type: EXPERIMENTAL
Intervention: Machine learning-derived early warning system (n=34)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard care (n=34)
Number of subjects: 68
Study: 34291275

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MedDiet) intervention
Number of subjects: 826

Group type: COMPARATOR
Intervention: Control group (no MedDiet)
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Higher baseline kynurenine:tryptophan ratio
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Higher levels of kynurenic acid
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Quinolinic acid
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Kynurenic acid
Number of subjects: 826
Study: 32164382

Group type: EXPERIMENTAL
Intervention: DVB-PVP cartridge
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of synbiotic treatment with DVB-PVP HD
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study: 34968662

Group type: EXPERIMENTAL
Intervention: Anti-microbial soap
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo soap
Number of subjects: 30
Study: 32800969

Group type: EXPERIMENTAL
Intervention: Yokukansan
Number of subjects: 195

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study: 32791792

Group type: EXPERIMENTAL
Intervention: Portal vein thrombosis (PVT) group
Number of subjects: 398
Study: 616625517

Group type: EXPERIMENTAL
Intervention: 3D CT overlay
Number of subjects: 30

Group type: COMPARATOR
Intervention: Contrast pulmonary venography
Number of subjects: 30
Study: 34115660

Group type: EXPERIMENTAL
Intervention: Cold Forceps (CF)
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: Cold Snare (CS)
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: Hot Snare (HS)
Number of subjects: 353
Study: 33501902

Group type: EXPERIMENTAL
Intervention: Individualised placement and support programme integrated with a personalised pain management plan.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Individualised placement and support programme
Number of subjects: 50

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 50

Group type: COMPARATOR
Intervention: Recruitment methods
Number of subjects: 50

Group type: COMPARATOR
Intervention: Retention of participants
Number of subjects: 50
Study: 33661810

Group type: EXPERIMENTAL
Intervention: 10 Hz visual stimulation
Number of subjects: 28

Group type: COMPARATOR
Intervention: 7 Hz visual stimulation
Number of subjects: 28
Study: 36147581

Group type: EXPERIMENTAL
Intervention: Oral contraceptives (combined formulations containing ethinyl estradiol 10-35 ug/day plus a synthetic progestin) during the active phase of OC use.
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Oral contraceptives (combined formulations containing ethinyl estradiol 10-35 ug/day plus a synthetic progestin) during the inactive phase of OC use.
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Oral contraceptives containing first- or second-generation progestins (the estrane family of progestins or OCs containing levonorgestrel).
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Oral contraceptives containing recently developed progestins and lower doses of ethinyl estradiol.
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Oral contraceptives (various brands classified by estrogenic strength).
Number of subjects: 201
Study: 33813930

Group type: EXPERIMENTAL
Intervention: Sound intervention
Number of subjects: 52

Group type: COMPARATOR
Intervention: Rest
Number of subjects: 52
Study: 32643265

Group type: EXPERIMENTAL
Intervention: Sub-threshold nano-second laser (SNL) treatment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 50
Study: 36205250

Group type: EXPERIMENTAL
Intervention: Microbial inoculant (Lactococcus lactis 0224 and Lactobacillus buchneri LB1819)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Bale moisture at 64.1%
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (no manure)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Slurry applied immediately to stubble (63,250 L/ha)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Slurry applied after a 1-wk delay (57,484 L/ha)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Aerobic exposure period (34 days)
Number of subjects: 48
Study: 34535130

Group type: EXPERIMENTAL
Intervention: Malaria prevention and elimination strategies implemented in Dembiya district.
Number of subjects: 735

Group type: EXPERIMENTAL
Intervention: Frequent outdoor activity
Number of subjects: 735

Group type: EXPERIMENTAL
Intervention: Awareness about malaria transmission
Number of subjects: 735
Study: 34854987

Group type: COMPARATOR
Intervention: RCT (Root Canal Therapy)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: PMTA (Pulpotomy with ProRoot MTA)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: PCEM (Pulpotomy with CEM cement)
Number of subjects: 157
Study: 32693009

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Dual-task training
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Walking program
Number of subjects: 126
Study: 33599975

Group type: EXPERIMENTAL
Intervention: Blonanserin transdermal patch
Number of subjects: 441
Study: 35948966

Group type: EXPERIMENTAL
Intervention: Flashing light (Flash)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Darkness (Dark)
Number of subjects: 10
Study: 33416202

Group type: EXPERIMENTAL
Intervention: ACT Raising Safe Kids parenting program
Number of subjects: 143
Study: 34131766

Group type: EXPERIMENTAL
Intervention: FRACTING score ≥ 7 at the immediate post-operative period
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: LEG‐NUI score ≥ 5 within 12 weeks
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: NURD score ≥ 9 at the immediate post-operative period
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: TFHS < 3 at 12 weeks
Number of subjects: 15
Study: 36372315

Group type: EXPERIMENTAL
Intervention: AuriAc (AEFI-specific auricular points applied, n = 52)
Number of subjects: 147

Group type: COMPARATOR
Intervention: SAuriAc (sham auricular acupressure, n = 51)
Number of subjects: 147

Group type: COMPARATOR
Intervention: TrAsU (treatment as usual, n = 44)
Number of subjects: 147
Study: 34187716

Group type: EXPERIMENTAL
Intervention: Foot-ankle flexibility and resistance exercise (3 times a week for 12 and 24 weeks)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Foot-ankle flexibility and resistance exercise
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (foot care education only)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 33280425

Group type: EXPERIMENTAL
Intervention: Insulin degludec
Number of subjects: 7637

Group type: COMPARATOR
Intervention: Insulin glargine 100 units/mL (glargine U100)
Number of subjects: 7637

Group type: EXPERIMENTAL
Intervention: History of heart failure
Number of subjects: 7637

Group type: EXPERIMENTAL
Intervention: History of hepatic impairment
Number of subjects: 7637
Study: 36221341

Group type: EXPERIMENTAL
Intervention: Combined therapy (acupuncture and moxibustion)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional western medicine
Number of subjects: 200
Study: 34477306

Group type: EXPERIMENTAL
Intervention: AI-assisted colonoscopy
Number of subjects: 2352

Group type: COMPARATOR
Intervention: Conventional colonoscopy (control group)
Number of subjects: 2352
Study: 32776649

Group type: EXPERIMENTAL
Intervention: Mechanical Insufflator-Exsufflator (MI-E)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Autogenic Drainage (AD)
Number of subjects: 22
Study: 34608048

Group type: EXPERIMENTAL
Intervention: Supervised 8- to 12-week physical exercise program
Number of subjects: 20

Group type: COMPARATOR
Intervention: Usual physical activity (control)
Number of subjects: 20
Study: 35157299

Group type: EXPERIMENTAL
Intervention: Fast Track Surgery (FTS) protocol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard protocol
Number of subjects: 30
Study: 32233095

Group type: EXPERIMENTAL
Intervention: Daunorubicin (DNR, 50 mg/m2) with standard-dose cytarabine and etoposide for induction chemotherapy and intermediate dose cytarabine for consolidation
Number of subjects: 2157

Group type: EXPERIMENTAL
Intervention: Mitoxantrone (MXR, 12 mg/m2) with standard-dose cytarabine and etoposide for induction chemotherapy and intermediate dose cytarabine for consolidation
Number of subjects: 2157

Group type: EXPERIMENTAL
Intervention: Idarubicin (IDA, 10 mg/m2) with standard-dose cytarabine and etoposide for induction chemotherapy and intermediate dose cytarabine for consolidation
Number of subjects: 2157

Group type: EXPERIMENTAL
Intervention: Allogeneic hematopoietic stem cell transplantation (HSCT) for patients with a HLA-identical sibling donor
Number of subjects: 2157

Group type: EXPERIMENTAL
Intervention: Autologous HSCT for patients without a HLA-identical sibling donor
Number of subjects: 2157
Study: 34099268

Group type: EXPERIMENTAL
Intervention: Music therapy (30-minute session)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no music session)
Number of subjects: 60
Study: 32990633

Group type: COMPARATOR
Intervention: Standard group with automated emails (S)
Number of subjects: 605

Group type: COMPARATOR
Intervention: Standard plus personalized SMS (S+pSMS)
Number of subjects: 605

Group type: COMPARATOR
Intervention: Standard plus weekly videoconferencing support (S+VCS)
Number of subjects: 605

Group type: COMPARATOR
Intervention: Participants who completed postquestionnaire (S)
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Participants who received their first preference in human support (S)
Number of subjects: 605
Study: 33395401

Group type: EXPERIMENTAL
Intervention: Undersized drilling
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional drilling
Number of subjects: 30
Study: 32962593

Group type: EXPERIMENTAL
Intervention: 0.5 mg.kg‐1 ketamine (group K1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 1 mg.kg‐1 ketamine (group K2)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Saline (group S)
Number of subjects: 75
Study: 36042460

Group type: EXPERIMENTAL
Intervention: Therapeutic thoracentesis (TT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Chest tube insertion (control)
Number of subjects: 10
Study: 33589705

Group type: EXPERIMENTAL
Intervention: Underweight BMI
Number of subjects: 1273

Group type: EXPERIMENTAL
Intervention: Overweight/obese BMI
Number of subjects: 1273

Group type: COMPARATOR
Intervention: Normal weight BMI
Number of subjects: 1273
Study: 33237965

Group type: EXPERIMENTAL
Intervention: Substance use (khat)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Never discussing safe sex with partner
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Attachment duration more than four years
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Desire to bear children
Number of subjects: 352
Study: 33991085

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for targeted‐therapy related fatigue (CBT‐TTF) delivered via FaceTime for iPad
Number of subjects: 36

Group type: COMPARATOR
Intervention: Waitlist control (WLC)
Number of subjects: 36
Study: 34174128

Group type: EXPERIMENTAL
Intervention: High dose multi-strain probiotic De Simone formulation (112.5 billion viable lyophilized bacteria per capsule) for 3 months
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 33892652

Group type: EXPERIMENTAL
Intervention: Paranasal air suction using a portable air sucker for 120 seconds
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo air suction (no paranasal air suction)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Paranasal air suction using a portable air sucker
Number of subjects: 86
Study: 35858876

Group type: EXPERIMENTAL
Intervention: mNGS
Number of subjects: 440

Group type: COMPARATOR
Intervention: multiplex PCR followed by mNGS if necessary
Number of subjects: 440
Study: 33600826

Group type: EXPERIMENTAL
Intervention: PACAP38 infusion (10 pmol/kg/minute)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: PACAP38 infusion (10 pmol/kg/minute) followed by sumatriptan (4 mg)
Number of subjects: 35

Group type: COMPARATOR
Intervention: PACAP38 infusion (10 pmol/kg/minute) followed by placebo (saline)
Number of subjects: 35
Study: 35100758

Group type: COMPARATOR
Intervention: Bulb aspirator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nasal‐oral aspirator
Number of subjects: 0
Study: 33465506

Group type: EXPERIMENTAL
Intervention: Real immersive VR environment
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham (2D images)
Number of subjects: 38
Study: 34865143

Group type: EXPERIMENTAL
Intervention: Daprodustat
Number of subjects: 3872

Group type: COMPARATOR
Intervention: Darbepoetin alfa
Number of subjects: 3872
Study: 34370500

Group type: EXPERIMENTAL
Intervention: Census tract-level disadvantage index score (DIS)
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: DIS ≥ 50th percentile (less disadvantage)
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: DIS < 50th percentile (more disadvantage)
Number of subjects: 444
Study: 33609340

Group type: EXPERIMENTAL
Intervention: Oberstaufen Schrothkur
Number of subjects: 98

Group type: COMPARATOR
Intervention: diabetes‐friendly holiday
Number of subjects: 98
Study: 33774765

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care services (PC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0
Study: 33846983

Group type: EXPERIMENTAL
Intervention: Lidocaine/prilocaine cream
Number of subjects: 37

Group type: COMPARATOR
Intervention: Lidocaine injection
Number of subjects: 37
Study: 35034431

Group type: COMPARATOR
Intervention: Corresponding unaffected-ear groups
Number of subjects: 90
Study: 34097856

Group type: EXPERIMENTAL
Intervention: Therapeutic anticoagulation (in-hospital oral rivaroxaban 20 mg or 15 mg daily for stable patients, or initial subcutaneous enoxaparin 1 mg/kg twice per day or intravenous unfractionated heparin for clinically unstable patients, followed by rivaroxaban to day 30)
Number of subjects: 615

Group type: COMPARATOR
Intervention: Prophylactic anticoagulation (standard in-hospital enoxaparin or unfractionated heparin)
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Therapeutic anticoagulation
Number of subjects: 615

Group type: COMPARATOR
Intervention: Prophylactic anticoagulation
Number of subjects: 615
Study: 36100826

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided transversus abdominis plane block (TAPB) with 20 mL 0.5% ropivacaine and patient-controlled intravenous analgesia (PCIA)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Patient-controlled intravenous analgesia (PCIA) alone
Number of subjects: 160
Study: 34077237

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with FOLFOX followed by chemoradiation
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with CP followed by chemoradiation
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: PET nonresponders who crossed over to CP after induction FOLFOX
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: PET nonresponders who crossed over to FOLFOX after induction CP
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: PET responders to induction FOLFOX during chemoradiation
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: PET responders to induction CP during chemoradiation
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: PET nonresponders during chemoradiation
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: PET responders to induction FOLFOX
Number of subjects: 241
Study: 32448797

Group type: EXPERIMENTAL
Intervention: Cannabis and cannabinoid-based products (CBP) derived from the cannabis plant
Number of subjects: 0
Study: 35932062

Group type: EXPERIMENTAL
Intervention: Home-based active case finding (HACF)
Number of subjects: 1076

Group type: COMPARATOR
Intervention: Telephonic active case finding (TACF)
Number of subjects: 1076
Study: 32057433

Group type: EXPERIMENTAL
Intervention: Protein-enhanced, semi-skimmed (1.5%) milk
Number of subjects: 712

Group type: EXPERIMENTAL
Intervention: Fair milk (fair price paid to the milk producers)
Number of subjects: 712

Group type: EXPERIMENTAL
Intervention: 100% local pasteurized milk (conventional and organic quality)
Number of subjects: 712

Group type: EXPERIMENTAL
Intervention: All-purpose, long-life, part-skimmed (2.5%) milk
Number of subjects: 712
Study: 34473085

Group type: EXPERIMENTAL
Intervention: Fourier shell correlation of two independent maps and phase randomization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Local resolution estimation and map sharpening techniques
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Map-model comparison using Q-scores and Fourier shell correlation plots
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Annotating the model with B factors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Detecting and validating water molecules and metal ions in maps
Number of subjects: 0
Study: 36137622

Group type: EXPERIMENTAL
Intervention: Understanding Persistent Pain (UPP) Digital Decision Aid Tool (DAT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60